Phenominer Database Results (1652 results)

 

How to display a graph
Strain Phenotype Conditions Study Experiment Name Sex Age # of Animals Formula Average Type Value Units SEM SD Method Method Duration Post Insult Type Post Insult Time Value Post Insult Time Unit Method Notes Clinical Measurement Notes Experiment Notes Record ID Study ID
BN/Crl body weight control condition Wallis RH, et al., Diabetologia 2004 Jun;47(6):1096-106. Epub 2004 May 26 body mass male 168 days 15 313.0 g 4.0 15.49 body weighing method 0 11292 66
BN.GK-(D2Wox30-D2Wox68)/Ox body weight control condition Wallace KJ, et al., Physiol Genomics 2004 Sep 16;19(1):1-10. Epub 2004 Jul 20. body mass female 90 days 17 174.0 g 4.0 16.49 body weighing method 0 11305 69
SHRSP/Izm body weight control condition Yao H, et al., Physiol Genomics. 2007 Feb 27;. body mass male 150 days 17 315.0 g 7.28 30.0 body weighing method 0 0 65509 567
SS/JrSeac body weight controlled sodium content diet (8 %) (for 35 days) Fukushima K, et al., Nucl Med Biol. 2010 Nov;37(8):1005-12. Epub 2010 Sep 1. body mass not specified 126 days 5 273.0 g 6.26 14.0 body weighing method 0.0 0 67256 733
SS/JrHsdMcwi body weight controlled sodium content diet (0.4 %) Moreno C, et al., Physiol Genomics 2003 Nov 11;15(3):243-57. body mass female 84 days 28 230.0 g 3.0 15.87 body weighing method 0.0 0 after catheterization and jacket attachment 67294 151
BN.GH-(D6Mit12-D6Rat15)/Mcwi body weight angiotensin II (5-50 ng/kg/min) (between 0.2 and 1 hours) then norepinephrine (0.1-1 ug/kg/min) (between 0.2 and 1 hours) then phenylephrine (4 ug/kg) (between 0 and 0 hours) Bilusic M, et al., Croat Med J. 2008 Oct;49(5):586-99. body mass male 132 days-146 days 16 299.9 g 6.0 24.0 body weighing method 0 11541 101
BN/Elh body weight angiotensin II (5-50 ng/kg/min) (between 0.2 and 1 hours) then norepinephrine (0.1-1 ug/kg/min) (between 0.2 and 1 hours) then phenylephrine (4 ug/kg) (between 0 and 0 hours) Bilusic M, et al., Croat Med J. 2008 Oct;49(5):586-99. body mass male 132 days-146 days 21 310.3 g 7.64 35.0 body weighing method 0 11555 101
BB.SHR-(D6Rat184-D6Rat3)/K body weight control condition Kloting I, et al., Biochem Biophys Res Commun 2001 May 4;283(2):399-405. body mass male 84 days 17 324.0 g 6.79 28.0 body weighing method 0.0 0 66144 324
SS.LEW-(D10Mit10-D10Mgh1)/Jr body weight controlled sodium content diet (2 %) (between 24 and 27 days) Garrett MR, et al., Genome Res 1998 Jul;8(7):711-23 body mass not specified 64 days-71 days 20 292.0 g 2.1 9.39 body weighing method 0 0 4 rats per cage, 2 SR/Jr 2 LEW/NCrl 64725 222
SS/Jr body weight controlled sodium content diet (2 %) (between 24 and 27 days) Garrett MR, et al., Genome Res 1998 Jul;8(7):711-23 body mass not specified 64 days-71 days 46 302.0 g 1.8 12.21 body weighing method 0 0 4 rats per cage, 2 SR/Jr 2 LEW/NCrl 64713 222
SS.LEW-(D5Mit9-D5Mco10)/Jr body weight controlled sodium content diet (2 %) (between 24 and 27 days) Garrett MR, et al., Genome Res 1998 Jul;8(7):711-23 body mass not specified 64 days-71 days 40 282.0 g 1.8 11.38 body weighing method 0 0 4 rats per cage, 2 SR/Jr 2 LEW/NCrl 64717 222
SS/Jr body weight controlled sodium content diet (4 %) (for 14 days) Garrett MR, et al., Physiol Genomics 2000 Jun 29;3(1):33-8. body mass male 53 days-67 days 10 297.0 g 5.0 15.81 body weighing method 0 0 66107 691
BN/Crl body weight control condition Wallis RH, et al., Diabetologia 2004 Jun;47(6):1096-106. Epub 2004 May 26 body mass female 168 days 23 200.0 g 5.0 23.98 body weighing method 0.0 0 67312 66
P.NP-(D4Rat119-D4Rat55)/Iusm body weight control condition Alam I, et al., J Bone Miner Res. 2010 Jan 8. body mass male 180 days 8 597.0 g 8.49 24.0 body weighing method 0.0 0 12757 308
SHR/N body weight control condition Ye P and West MJ, Clin Exp Pharmacol Physiol 2003 Dec;30(12):930-6. body mass male 84 days 14 441.0 g 26.0 97.28 body weighing method 0 13046 327
SDT/Jcl body weight specific pathogen-free condition then fasting (for 16 hours) Fuse M, et al., Physiol Genomics. 2008 Jul 8;. body mass male 420 days 5 334.2 g 7.6 16.99 body weighing method 0.0 0 11605 106
F344.GK-(D1Mgh10-D1Rat119)/Swe body weight control condition (for 95 days) Galli J, et al., Diabetes 1999 Dec;48(12):2463-70. body mass male 95 days 11 305.0 g 5.0 16.58 body weighing method 0.0 0 11445 85
ACI.FHH-(D1Rat298-D1Rat90)/Eur body weight right nephrectomy Van Dijk SJ, et al., Kidney Int. 2006 body mass male 168 days-175 days 12 330.0 g 6.0 20.78 body weighing method 0.0 0 11951 62
SS/Jr body weight controlled sodium content diet (0.3 %) (between 10 and 12 days) then controlled sodium content diet (2 %) (for 24 days) Saad Y, et al., Hypertension. 2007 body mass male 64 days-66 days 0 331.0 g 2.08 body weighing method 0 11975 205
SS.LEW-(D10Mco84-D10Rat58)/Mco body weight controlled sodium content diet (0.3 %) (between 10 and 12 days) then controlled sodium content diet (2 %) (for 24 days) Saad Y, et al., Hypertension. 2007 body mass male 64 days-66 days 0 311.0 g 4.21 body weighing method 0 11980 205
F344.OLETF-(D14Rat8-D14Rat26)/2Tj body weight fasting (for 16 hours) Kose H, et al., Mamm Genome 2002 Oct;13(10):558-62. body mass male 210 days 15 384.0 g 3.4 13.17 body weighing method 0 11991 230
OLETF/Got body weight control condition Muramatsu Y, et al., Biochem Biophys Res Commun 2005 Jun 17;331(4):1270-6. body mass male 245 days 12 605.2 g 7.36 25.5 body weighing method 0 12437 262
SS/Jr body weight controlled sodium content diet (0.3 %) (between 10 and 12 days) then controlled sodium content diet (2 %) (for 28 days) Saad Y, et al., Physiol Genomics 2001 Jan 19;4(3):201-14. body mass male 68 days-70 days 20 304.0 g 2.95 13.19 body weighing method 0 12488 266
SS/Jr body weight controlled sodium content diet (0.3 %) (between 10 and 12 days) then controlled sodium content diet (2 %) (for 28 days) Saad Y, et al., Physiol Genomics 2001 Jan 19;4(3):201-14. body mass male 68 days-70 days 20 308.0 g 1.68 7.51 body weighing method 0 12489 266
SS.LEW-(D1Rat196-D1Mgh7)/Jr body weight controlled sodium content diet (0.3 %) (between 10 and 12 days) then controlled sodium content diet (2 %) (for 28 days) Saad Y, et al., Physiol Genomics 2001 Jan 19;4(3):201-14. body mass male 68 days-70 days 20 294.0 g 3.72 16.64 body weighing method 0 12501 266
SS.LEW-(D1Uia8-D1Rat124)/Mco body weight controlled sodium content diet (0.3 %) (between 10 and 12 days) then controlled sodium content diet (2 %) (for 28 days) Saad Y, et al., Physiol Genomics 2001 Jan 19;4(3):201-14. body mass male 68 days-70 days 20 298.0 g 2.53 11.31 body weighing method 0 12506 266
SS.LEW-(D1Uia8-D1Rat213)/Mco body weight controlled sodium content diet (0.3 %) (between 10 and 12 days) then controlled sodium content diet (2 %) (for 28 days) Saad Y, et al., Physiol Genomics 2001 Jan 19;4(3):201-14. body mass male 68 days-70 days 20 277.0 g 5.53 24.73 body weighing method 0 12507 266
BC/CpbU body weight controlled olive oil content diet (5 %) (for 28 days) and controlled cholesterol content diet (2 %) (for 28 days) Bonne AC, et al., Arterioscler Thromb Vasc Biol 2002 Dec 1;22(12):2072-9. body mass female 77 days 6 177.0 g 1.63 4.0 body weighing method 0 12606 271
SS.SHR-(D9Wox16-D9Mco73)/Mco body weight controlled sodium content diet (2 %) (for 28 days) Toland EJ, et al., J Hypertens. 2008 Nov;26(11):2134-41. body mass male 68 days-70 days 20 328.0 g 7.67 34.3 body weighing method 0 12952 305
BB.SHR-(D6Rat184-D6Rat3)/K body weight control condition Kloting I, et al., Biochem Biophys Res Commun 2001 May 4;283(2):399-405. body mass female 84 days 24 200.0 g 3.06 15.0 body weighing method 0.0 0 12976 324
WOKW body weight control condition Kloting I, et al., Biochem Biophys Res Commun 2001 Jun 1;284(1):150-6. body mass female 210 days 12 255.0 g body weighing method 0.0 0 12398 251
SS.SHR-(D13Rat63-D13Mit1)/Mco body weight controlled sodium content diet (0.3 %) Packard M, et al., Am J Physiol Renal Physiol. 2009 Apr;296(4):F839-46. Epub 2009 Jan 28. body mass male 84 days 12 397.0 g 3.4 11.78 body weighing method 0 0 12333 246
ACI.FHH-(D3Wox2-D3Rat59)/Eur body weight control condition Van Dijk SJ, et al., Kidney Int. 2006 body mass male 168 days-175 days 12 314.0 g 3.0 10.39 body weighing method 0.0 0 11926 62
SS.SR-(Cyp11b1)/Jr body weight controlled sodium content diet (1 %) (for 30 days) then controlled sodium content diet (0.2 %) (for 40 days) Cicila GT, et al., Mamm Genome 1997 Dec;8(12):896-902. body mass male 100 days 16 336.7 g 6.7 26.8 body weighing method 0 11786 146
SS/Jr body weight controlled sodium content diet (0.3 %) (between 10 and 12 days) then controlled sodium content diet (2 %) (between 24 and 27 days) Cicila GT, et al., Genomics 2001 Feb 15;72(1):51-60. body mass male 68 days-70 days 20 289.8 g 3.2 14.31 body weighing method 0 11817 147
OLETF/Got body weight control condition Ogino Genom 2000 Nov 15;70(1):19-25. body mass male 245 days-252 days 14 650.6 g 8.61 32.2 body weighing method 0 11406 83
SR/Jr body weight controlled sodium content diet (0.2 %) (for 28 days) Garrett MR, et al., Genome Res 1998 Jul;8(7):711-23 body mass male 63 days 10 238.0 g 4.7 14.86 body weighing method 0 0 4 rats per cage, 2 SR/Jr 2 LEW/NCrl 12180 222
SS/Jr body weight controlled sodium content diet (0.3 %) (between 10 and 12 days) then controlled sodium content diet (2 %) (for 24 days) Toland EJ, et al., Mamm Genome. 2008 Mar;19(3):209-18. Epub 2008 Mar 7. body mass male 64 days-66 days 20 314.0 g 2.23 9.97 body weighing method 0.0 0 12863 313
WKY body weight controlled sodium content diet (0.4 %) (for 122 days) then controlled sodium content diet (1.4 %) (for 210 days) Inomata H, et al., Hypertens Res 2005 Mar;28(3):273-81. body mass male 360 days 4 318.0 g 6.65 13.3 body weighing method 0 0 12588 268
LEW/Crlc body weight gain controlled sodium content diet (8 %) (between 8 and 10 days) Huang BS, et al., Hypertension. 2007 Apr 9;. body mass male 43 days-52 days 8 54.0 g 3.0 8.49 body weighing method 0 13315 344
SS.LEW-(D10Chm10-D10Rat11)/Ayd body weight gain controlled sodium content diet (8 %) (between 8 and 10 days) Huang BS, et al., Hypertension. 2007 Apr 9;. body mass male 43 days-52 days 10 53.0 g 3.0 9.49 body weighing method 0 13316 344
SS.MNS-(D2Chm25-D2Rat131)/Ayd body weight controlled sodium content diet (2 %) (between 35 and 98 days) Duong C, et al., Mamm Genome 2006; 17(12): 1147-1161 body mass male 98 days 5 394.0 g 0.8 1.79 body weighing method 0 0 12031 226
F344.OLETF-(D5Mgh4-D5Rat21)/Tj body weight fasting (for 16 hours) Kose H, et al., Mamm Genome 2002 Oct;13(10):558-62. body mass male 210 days 10 352.5 g 4.4 13.91 body weighing method 0 12034 230
SS.LEW-(D17Chm14-D17Rat181)/Ayd body weight controlled sodium content diet (2 %) (between 35 and 98 days) Duong C, et al., Mamm Genome 2006; 17(12): 1147-1161 body mass male 98 days 5 377.0 g 9.0 20.12 body weighing method 0 0 12069 226
SS/Jr body weight controlled sodium content diet (2 %) (for 24 days) Saad Y, et al., Mamm Genome. 2008 Jan 4 body mass male 64 days-68 days 20 307.0 g 2.02 9.03 body weighing method 0 0 12145 232
SS/HsdMcwiCrl body weight to tibia length ratio controlled carbohydrate content diet (69 %) (for 91 days) and controlled fat content diet (12 %) (for 91 days) and controlled protein content diet (19 %) (for 91 days) Spradley FT, et al., Am J Physiol Regul Integr Comp Physiol. 2012 Jan 1;302(1):R150-8. Epub 2011 Oct 26. body mass male 112 days 6 96.12 g/cm 1.28 3.14 body weighing method 0.0 0 67616 735
F344/Jcl body weight control condition Yamashita S, et al., Cancer Res 2005 Apr 1;65(7):2610-6. body mass male 900 days 8 null 350.7 g body weighing method 0 method not specified, assumed to be digital scale 13302 341
SS.SHR-(D9Mco72-D9Mco109)/Mco body weight controlled sodium content diet (0.3 %) (between 10 and 12 days) then controlled sodium content diet (2 %) (between 25 and 28 days) Kumarasamy S, et al., Hypertens Res. 2011 Dec;34(12):1263-70. doi: 10.1038/hr.2011.116. Epub 2011 Aug 4. body mass not specified 0 days 0 307.0 g 2.84 body weighing method 0.0 0 67530 749
SS/Jr body weight controlled sodium content diet (0.3 %) (between 10 and 12 days) then controlled sodium content diet (2 %) (between 25 and 28 days) Kumarasamy S, et al., Hypertens Res. 2011 Dec;34(12):1263-70. doi: 10.1038/hr.2011.116. Epub 2011 Aug 4. body mass not specified 0 days 0 296.0 g 14.72 body weighing method 0.0 0 67533 749
SHR.BN-(D2Rat114-D2Rat123)/Jk body weight controlled sodium content diet (1 %) (for 14 days) Aneas I, et al., Physiol Genomics. 2009 Mar 3;37(1):52-7. Epub 2009 Jan 6. body mass male 87 days 23 273.0 g 7.0 33.57 body weighing method 0 0 65431 306
SHR.BN-(D4Rat33-D4Rat54)/Jk body weight controlled sodium content diet (1 %) (for 14 days) Aneas I, et al., Physiol Genomics. 2009 Mar 3;37(1):52-7. Epub 2009 Jan 6. body mass male 87 days 23 275.0 g 4.0 19.18 body weighing method 0 0 65435 306
SHR.BN-(D16Rat87-D16Mgh1)/Jk body weight controlled sodium content diet (1 %) (for 14 days) Aneas I, et al., Physiol Genomics. 2009 Mar 3;37(1):52-7. Epub 2009 Jan 6. body mass male 87 days 23 271.0 g 5.0 23.98 body weighing method 0 0 65437 306
LEW/Cub body weight losartan (10 mg/kg) (for 0.2 hours) then pentolinium (5 mg/kg) (for 0.1 hours) then NG-nitroarginine methyl ester (30 mg/kg) (for 0.3 hours) Ueno T, et al., Physiol Res 2003;52(6):689-700. body mass not specified 0 days 9 serial mean 300.2 g body weighing method 0 0 65439 568
WKY/Izm body weight control condition (0 null) Kato N, et al., Hypertension 2003 DXCO;42(6):1191-7. body mass female 91 days 5 200.8 g 3.1 6.93 body weighing method 0 0 64833 115
SHR/NHsd body weight control condition Garrett MR, et al., J Am Soc Nephrol 2003 May;14(5):1175-87 body mass male 182 days-183 days 6 392.0 g 7.0 17.15 body weighing method 0 0 65447 104
SS-Chr 19SHR/Rkb body weight controlled sodium content diet (4 %) (for 56 days) Wendt N, et al., J Hypertens. 2007 Jan;25(1):95-102. body mass male 98 days 20 355.0 g 9.0 40.25 body weighing method 0 0 66085 669
SS/Hsd cubic root of body weight to nasoanal length ratio controlled sodium content diet (0.3 %) then fasting (for 16 hours) Herrera VL, et al., Circ Res 2004 Mar 5; 94(4):446-52 body mass male 180 days 20 315.4 g/mm x 10000 1.87 8.36 body weighing method 0.0 0 67893 204
DA/K body weight control condition Kovacs P, et al., Biochem Biophys Res Commun 2000 Mar 24;269(3):660-5. body mass not specified 224 days 12 254.0 g 9.53 33.0 body weighing method 0.0 0 69109 1123
PD/Cub body weight controlled sucrose content diet (for 7 days) then dexamethasone (0.03 mg/ml) (for 3 days) Seda O, et al., Physiol Genomics. 2005 Apr 14;21(2):243-52. Epub 2005 Feb 22. body mass male 310 days 6 352.9 g 1.55 3.8 body weighing method 0.0 0 70211 1318
ACI.FHH-(D1Mit18-D1Mit8)(D14Mit11-D14Hmgc14b)(D14Rat65-D14Rat90)/Eur body weight unilateral nephrectomy then NG-nitroarginine methyl ester (10-21 ml/kg/d) (for 126 days) van Dijk SJ, et al., Nephron Exp Nephrol. 2006;104(3):e96-e102. Epub 2006 Jul 12. body mass not specified 168 days-175 days 2 286.0 g 1.0 1.41 body weighing method 0.0 unilateral nephrectomy 126 days 67909 832
DA/K body mass index (BMI) control condition Kloting I, et al., Biochem Biophys Res Commun 2001 Jun 1;284(1):150-6. body mass female 224 days 12 0.51 g/cm2 body weighing method 0.0 0 67914 251
DA/ZtmKini maximum body weight loss to initial body weight ratio myelin oligodendrocyte glycoprotein (20 ug) Jagodic M, et al., Immunogenetics 2001 Jul;53(5):410-5. body mass male 103 days-131 days 11 14.4 % 2.47 8.2 body weighing method 0.0 intradermal injection 40 days from before p.i. CMO:0001400 68134 839
DA/ZtmKini maximum body weight loss to initial body weight ratio myelin oligodendrocyte glycoprotein (20 ug) Jagodic M, et al., Immunogenetics 2001 Jul;53(5):410-5. body mass male 103 days-131 days 10 3.5 % 1.49 4.7 body weighing method 0.0 intradermal injection 40 days from before p.i. 68708 839
E3/Ztm body weight gain spinal cord homogenate (10 mg) Bergsteinsdottir K, et al., J Immunol 2000 Feb 1;164(3):1564-8 body mass female 56 days-103 days 12 80.0 g 0.87 3.0 body weighing method 0.0 0 69956 1258
DA/ZtmKini body weight control condition Stridh P, et al., PLoS One. 2010 Sep 15;5(9):e12716. body mass female 56 days-77 days 0 162.9 g 9.5 body weighing method 0.0 0 68120 837
COP.DA-(D16Rat12-D16Rat90)/Mco body weight control condition Ways JA, et al., Physiol Genomics. 2006 Dec 19;. body mass not specified 105 days 8 275.6 g 4.6 13.01 body weighing method 0.0 0 68487 933
DA/Ztm maximum body weight loss to initial body weight ratio type II collagen (500 ug) and Freund's incomplete adjuvant (100 ul) Backdahl L, et al., Arthritis Rheum 2003 Feb;48(2):551-9. body mass both 120 days-200 days 12 13.4 % 1.4 4.85 body weighing method 0.0 0 69798 1162
DA.PVG.1AV1-(D4Rat155-D4Rat84) maximum body weight loss to initial body weight ratio pristane (150 ul) Backdahl L, et al., Arthritis Rheum 2003 Feb;48(2):551-9. body mass both 120 days-200 days 16 8.8 % 2.2 8.8 body weighing method 0.0 0 69805 1162
DA.PVG.1AV1-(D4Rat155-Spr) maximum body weight loss to initial body weight ratio pristane (150 ul) Backdahl L, et al., Arthritis Rheum 2003 Feb;48(2):551-9. body mass both 120 days-200 days 24 10.6 % 1.1 5.39 body weighing method 0.0 0 69806 1162
DA.PVG.1AV1-(D4Rat63-D4Rat203) maximum body weight loss to initial body weight ratio squalene (200 ul) Backdahl L, et al., Arthritis Rheum 2003 Feb;48(2):551-9. body mass both 120 days-200 days 10 6.6 % 2.5 7.91 body weighing method 0.0 0 69808 1162
DA.PVG.1AV1-(D4Rat63-D4Rat203) maximum body weight loss to initial body weight ratio pristane (150 ul) Backdahl L, et al., Arthritis Rheum 2003 Feb;48(2):551-9. body mass both 120 days-200 days 10 12.6 % 2.7 8.54 body weighing method 0.0 0 69812 1162
SS/JrHsdMcwi body weight controlled sodium content diet (4 %) (for 21 days) Mattson DL, et al., Am J Physiol Regul Integr Comp Physiol. 2013 Jan 30. body mass not specified 84 days 0 395.0 g 10.0 body weighing method 0.0 0 69205 1057
Crl:CD(SD) body weight standard diet then acetaminophen (300 mg/kg) (for 1 days) Kondo K, et al., J Toxicol Sci. 2012;37(5):911-29. body mass male 71 days 8 371.0 g 5.66 16.0 body weighing method 0.0 0 85519 1604
Crl:CD(SD) body weight standard diet and restricted feeding (4 h) then acetaminophen (300 mg/kg) (for 1 days) Kondo K, et al., J Toxicol Sci. 2012;37(5):911-29. body mass male 71 days 8 287.0 g 6.72 19.0 body weighing method 0.0 0 85522 1604
Crl:CD(SD) body weight standard diet then acetaminophen (500 mg/kg) (for 56 days) Kondo K, et al., J Toxicol Sci. 2012;37(5):911-29. body mass male 126 days 8 516.0 g 12.73 36.0 body weighing method 0.0 0 85538 1604
HanTac:WH body weight vehicle control condition (between 16 and 17 days) Christiansen S, et al., Reproduction. 2014 Mar 2;147(4):477-87. doi: 10.1530/REP-13-0377. Print 2014. body mass female 16 days-17 days 15 29.1 g 0.67 2.6 body weighing method 0.0 0 96687 1559
W/Nin body weight controlled retinyl palmitate content diet (2.6 mg/kg) (between 36 and 42 days) then fasting (for 12 hours) Tiruvalluru M, et al., Nutrition. 2013 Jan;29(1):298-304. doi: 10.1016/j.nut.2012.06.006. Epub 2012 Oct 2. body mass male 284 days 6 424.0 g 19.8 48.5 body weighing method 0.0 0 96717 1660
BluHsd:LE body weight controlled in utero environment (for 9 days) and bisphenol A (2.5 ug/kg) (for 30 days) then maternal milk (for 21 days) Nanjappa MK, et al., Toxicol Lett. 2014 Mar 21;225(3):479-87. doi: 10.1016/j.toxlet.2014.01.024. Epub 2014 Jan 26. body mass male 70 days 8 339.6 g 9.5 26.87 body weighing method 0.0 0 76146 1543
BluHsd:LE body weight controlled in utero environment (for 9 days) and bisphenol A (25 ug/kg) (for 30 days) then maternal milk (for 21 days) then controlled fat content diet (21.2 %) (for 28 days) Nanjappa MK, et al., Toxicol Lett. 2014 Mar 21;225(3):479-87. doi: 10.1016/j.toxlet.2014.01.024. Epub 2014 Jan 26. body mass male 98 days 8 486.9 g 8.7 24.61 body weighing method 0.0 0 76155 1543
F344/NHsd body weight control condition Mach J, et al., J Gerontol A Biol Sci Med Sci. 2013 Jul 17. body mass male 579 days-945 days 9 424.8 g 14.5 43.5 body weighing method 0.0 0 84701 1599
SD body weight control condition Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. body mass male 64 days-78 days 6 246.1 g body weighing method 0.0 0 84786 1602
SD body weight control condition Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. body mass female 50 days-64 days 6 148.3 g body weighing method 0.0 0 84795 1602
SD body weight acetaminophen (1000 mg/kg) (for 1 days) Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. body mass female 42 days-56 days 6 134.2 g body weighing method 0.0 0 84809 1602
SD body weight acetaminophen (1000 mg/kg) (for 8 days) Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. body mass female 50 days-64 days 6 146.1 g body weighing method 0.0 0 84820 1602
CrljJcl:SD body weight gestation (for 20 days) Xu X, et al., Neurotoxicol Teratol. 2011 Jul-Aug;33(4):458-63. doi: 10.1016/j.ntt.2011.06.002. Epub 2011 Jun 17. body mass female 0 days 6 355.48 g 29.85 73.12 body weighing method 0.0 0 75902 1539
CrljJcl:SD body weight gestation (for 21 days) then lactation (for 14 days) Xu X, et al., Neurotoxicol Teratol. 2011 Jul-Aug;33(4):458-63. doi: 10.1016/j.ntt.2011.06.002. Epub 2011 Jun 17. body mass female 0 days 6 264.54 g 14.41 35.3 body weighing method 0.0 0 75904 1539
CrljJcl:SD body weight gestation (for 14 days) then controlled bisphenol A content drinking water (0.1 mg/l) (for 3 days) Xu X, et al., Neurotoxicol Teratol. 2011 Jul-Aug;33(4):458-63. doi: 10.1016/j.ntt.2011.06.002. Epub 2011 Jun 17. body mass female 0 days 8 287.17 g 20.44 57.81 body weighing method 0.0 0 75911 1539
CrljJcl:SD body weight gestation (for 21 days) then controlled bisphenol A content drinking water (0.1 mg/l) (for 17 days) then lactation (for 7 days) Xu X, et al., Neurotoxicol Teratol. 2011 Jul-Aug;33(4):458-63. doi: 10.1016/j.ntt.2011.06.002. Epub 2011 Jun 17. body mass female 0 days 8 265.19 g 15.46 43.73 body weighing method 0.0 0 75913 1539
CrljJcl:SD body weight gestation (for 21 days) then controlled bisphenol A content drinking water (1 mg/l) (for 17 days) then lactation (for 7 days) Xu X, et al., Neurotoxicol Teratol. 2011 Jul-Aug;33(4):458-63. doi: 10.1016/j.ntt.2011.06.002. Epub 2011 Jun 17. body mass female 0 days 8 259.23 g 24.17 68.36 body weighing method 0.0 0 75918 1539
Hsd:WI body weight 1H-pyrazole (10 mg/kg/d) (for 10 days) then cisplatin (7.5 mg/kg) Prabhu VV, et al., Pharmacol Rep. 2013;65(4):980-90. body mass male 0 days 6 142.5 g 0.73 1.8 body weighing method 0.0 0 75953 1544
Hsd:WI body weight silymarin (50 mg/kg/d) (for 10 days) then cisplatin (7.5 mg/kg) Prabhu VV, et al., Pharmacol Rep. 2013;65(4):980-90. body mass male 0 days 6 143.6 g 0.41 1.0 body weighing method 0.0 0 75954 1544
BluHsd:LE body weight controlled in utero environment (for 9 days) and bisphenol A (2.5 ug/kg) (for 30 days) then maternal milk (for 21 days) Nanjappa MK, et al., Toxicol Lett. 2014 Mar 21;225(3):479-87. doi: 10.1016/j.toxlet.2014.01.024. Epub 2014 Jan 26. body mass male 70 days 8 338.8 g 9.9 28.0 body weighing method 0.0 0 75960 1543
Hsd:WI body weight octylphenol (125 mg/kg/d) (for 91 days) Yildiz N and Barlas N, Hum Exp Toxicol. 2013 Jul;32(7):675-86. doi: 10.1177/0960327112464796. body mass male 119 days-126 days 6 326.67 g 14.98 36.69 body weighing method 0.0 0 76047 1545
SD body weight control condition Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. body mass male 50 days-64 days 6 207.4 g body weighing method 0.0 0 84761 1602
Hsd:WI change in body weight to body weight ratio octylphenol (125 mg/kg/d) (for 91 days) Yildiz N and Barlas N, Hum Exp Toxicol. 2013 Jul;32(7):675-86. doi: 10.1177/0960327112464796. body mass male 119 days-126 days 6 242.2 % 18.74 45.9 body weighing method 0.0 0 76068 1545
Crl:SD body weight controlled fructose content drinking water (5 %) and controlled bisphenol A content drinking water (0.025 mg/l) Ronn M, et al., Toxicology. 2013 Jan 7;303:125-32. doi: 10.1016/j.tox.2012.09.013. Epub 2012 Nov 8. body mass female 35 days 12 84.7 g 3.2 11.1 body weighing method 0.0 0 week one 75749 1538
HanTac:WH body weight bisphenol A (0.25 mg/kg/d) (for 1 days) Christiansen S, et al., Reproduction. 2014 Mar 2;147(4):477-87. doi: 10.1530/REP-13-0377. Print 2014. body mass male 1 days 17 6.1 g 0.12 0.5 body weighing method 0.0 0 96614 1559
Crl:CD(SD) body weight standard diet and restricted feeding (4 h) Kondo K, et al., J Toxicol Sci. 2012;37(5):911-29. body mass male 84 days 19 328.0 g 4.82 21.0 body weighing method 0.0 0 85313 1604
PXO5-1/Cub body weight controlled sucrose content diet (70 % of calories) (between 0 and 168 hours) and controlled protein content diet (19.6 % of calories) (between 0 and 168 hours) and controlled fat content diet (10.4 % of calories) (between 0 and 168 hours) then fasting (between 0 and 16 hours) Hodulova M, et al., PLoS One. 2014 Oct 8;9(10):e109983. doi: 10.1371/journal.pone.0109983. eCollection 2014. body mass male 127 days 11 235.1 g 4.8 15.92 body weighing method 0.0 0 97158 1858
SHR-Ndufc2em1Mcwi+/+ body weight controlled protein content diet (19.7 %) (for 84 days) and controlled potassium content diet (6.3 mg/g) (for 84 days) and controlled sodium content diet (3.7 mg/g) (for 84 days) Rubattu S, et al., J Am Heart Assoc. 2016 Feb 17;5(2). pii: e002701. doi: 10.1161/JAHA.115.002701. body mass not specified 126 days 10 309.0 g 8.54 27.0 body weighing method 0.0 0 97879 1938
SHR-Ndufc2em2Mcwi-/+ body weight controlled protein content diet (19.7 %) (for 84 days) and controlled potassium content diet (6.3 mg/g) (for 84 days) and controlled sodium content diet (3.7 mg/g) (for 84 days) Rubattu S, et al., J Am Heart Assoc. 2016 Feb 17;5(2). pii: e002701. doi: 10.1161/JAHA.115.002701. body mass not specified 126 days 16 312.0 g 9.0 36.0 body weighing method 0.0 0 97905 1938
SHR/Bbb body weight controlled protein content diet (19.7 %) (for 28 days) and controlled potassium content diet (6.3 mg/g) (for 28 days) and controlled sodium content diet (3.7 mg/g) (for 28 days) Rubattu S, et al., J Am Heart Assoc. 2016 Feb 17;5(2). pii: e002701. doi: 10.1161/JAHA.115.002701. body mass not specified 70 days 18 220.0 g 3.06 13.0 body weighing method 0.0 0 97906 1938
SD body weight control condition Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. body mass female 57 days-71 days 6 151.6 g body weighing method 0.0 0 84816 1602
SD body weight control condition Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. body mass female 70 days-84 days 6 160.5 g body weighing method 0.0 0 84818 1602
SS-Nppbem2Mcwi-/- body weight control condition (for 84 days) Holditch SJ, et al., Hypertension. 2015 Jul;66(1):199-210. doi: 10.1161/HYPERTENSIONAHA.115.05610. Epub 2015 May 11. body mass male 84 days 10 378.0 g 20.0 63.25 body weighing method 0.0 0 99548 2319
SS-Nppbem2Mcwi+/+ body weight control condition (for 252 days) Holditch SJ, et al., Hypertension. 2015 Jul;66(1):199-210. doi: 10.1161/HYPERTENSIONAHA.115.05610. Epub 2015 May 11. body mass male 252 days 6 462.0 g 19.0 46.54 body weighing method 0.0 0 99551 2319
MW body weight right nephrectomy (for 56 days) then enalapril (20 mg/kg/d) Kakinuma Y, et al., Kidney Int. 1992 Jul;42(1):46-55. body mass male 0 days 9 280.5 g 1.1 3.3 body weighing method 0.0 ~5/6 to 7/8 nephrectomy 56 days 100802 2523
PXO6-1/Cub body weight controlled sucrose content diet (70 % of calories) (between 0 and 168 hours) and controlled protein content diet (19.6 % of calories) (between 0 and 168 hours) and controlled fat content diet (10.4 % of calories) (between 0 and 168 hours) then fasting (between 0 and 16 hours) Hodulova M, et al., PLoS One. 2014 Oct 8;9(10):e109983. doi: 10.1371/journal.pone.0109983. eCollection 2014. body mass male 127 days 10 251.2 g 5.5 17.39 body weighing method 0.0 0 97162 1858
SR/JrHsd body weight control condition Zheng W, et al., Am J Physiol Heart Circ Physiol. 2008 Apr;294(4):H1508-13. doi: 10.1152/ajpheart.01322.2007. Epub 2008 Feb 1. body mass female 0 days 0 212.0 g 4.4 body weighing method 0.0 0 102181 2681
SR/JrHsd body weight controlled sodium chloride content diet (0.4 %) (for 14 days) then bilateral ovariectomy then peanut oil (0.2 ml) (for 14 days) Zheng W, et al., Am J Physiol Heart Circ Physiol. 2008 Apr;294(4):H1508-13. doi: 10.1152/ajpheart.01322.2007. Epub 2008 Feb 1. body mass female 0 days 0 276.0 g 11.0 body weighing method 0.0 0 102185 2681
SR/JrHsd body weight controlled sodium chloride content diet (4 %) (for 14 days) then bilateral ovariectomy then peanut oil (0.2 ml) (for 14 days) Zheng W, et al., Am J Physiol Heart Circ Physiol. 2008 Apr;294(4):H1508-13. doi: 10.1152/ajpheart.01322.2007. Epub 2008 Feb 1. body mass female 0 days 0 269.0 g 7.3 body weighing method 0.0 0 102186 2681
SS/JrHsd body weight controlled sodium chloride content diet (4 %) (for 14 days) then sham surgical control condition then peanut oil (0.2 ml) (for 14 days) Zheng W, et al., Am J Physiol Heart Circ Physiol. 2008 Apr;294(4):H1508-13. doi: 10.1152/ajpheart.01322.2007. Epub 2008 Feb 1. body mass female 0 days 0 235.0 g 13.0 body weighing method 0.0 0 102190 2681
LH/Mav body weight vehicle control condition Emonnot L, et al., J Hypertens. 2007 Feb;25(2):429-38. body mass male 112 days 11 384.0 g 9.0 29.85 body weighing method 0.0 0 102724 2721
WKY body weight left anterior descending coronary artery occlusion then furosemide Rokutan H, et al., Int J Cardiol. 2012 Sep 20;160(1):20-5. doi: 10.1016/j.ijcard.2011.03.005. Epub 2011 Mar 29. body mass male 42 days-56 days 20 225.0 g 3.0 13.42 body weighing method 0.0 lad occlusion 0 days 100268 2460
SR body weight controlled sodium content diet (6 %) (between 21 and 28 days) Kamei K, et al., Circ J. 2007 Mar;71(3):390-6. body mass male 63 days-70 days 7 303.0 g 10.96 29.0 body weighing method 0.0 0 103344 2804
SR body weight controlled sodium content diet (6 %) (between 35 and 49 days) Kamei K, et al., Circ J. 2007 Mar;71(3):390-6. body mass male 77 days-91 days 7 360.0 g 9.83 26.0 body weighing method 0.0 0 103345 2804
LH/Mav body weight controlled losartan content drinking water (10 mg/kg/d) (for 63 days) Bertram D, et al., Am J Physiol Regul Integr Comp Physiol. 2002 Nov;283(5):R1041-5. doi: 10.1152/ajpregu.00620.2001. body mass male 147 days-154 days 5 432.0 g 11.0 24.6 body weighing method 0.0 0 103429 2825
LH/Mav body weight controlled perindopril content drinking water (3 mg/kg/d) (for 63 days) Bertram D, et al., Am J Physiol Regul Integr Comp Physiol. 2002 Nov;283(5):R1041-5. doi: 10.1152/ajpregu.00620.2001. body mass male 147 days-154 days 6 436.0 g 8.0 19.6 body weighing method 0.0 0 103431 2825
WKY/NCrl body weight control condition Alameddine A, et al., J Physiol Pharmacol. 2015 Apr;66(2):249-57. body mass male 140 days 6 437.0 g 3.0 7.35 body weighing method 0.0 0 103487 2827
GK body weight salidroside (40 mg/kg) (for 28 days) Alameddine A, et al., J Physiol Pharmacol. 2015 Apr;66(2):249-57. body mass male 168 days 6 367.0 g 7.0 17.15 body weighing method 0.0 0 103493 2827
OLETF body weight control condition (for 84 days) Koga K, et al., Mol Med. 2002 Oct;8(10):591-9. body mass male 364 days 12 748.6 g 33.0 114.32 body weighing method 0.0 0 99411 2298
FHH-Nr4a1m1Mcwi body weight control condition Westbrook L, et al., J Am Soc Nephrol. 2014 Nov;25(11):2499-510. doi: 10.1681/ASN.2013070786. Epub 2014 Apr 10. body mass male 168 days 6 352.0 g 14.0 34.29 body weighing method 0.0 0 99456 2318
WKY body weight in utero condition (30 % of calories) (for 22 days) Riviere G, et al., Hypertension. 2005 Nov;46(5):1169-74. Epub 2005 Oct 3. body mass not specified 1 days 36 4.91 g 0.15 0.9 body weighing method 0.0 0 99074 2218
SS/NEisSlc body weight controlled sodium chloride content diet (0.3 %) (for 42 days) then controlled sodium chloride content diet (8 %) (for 35 days) Horinaka S, et al., Int J Cardiol. 2003 Sep;91(1):25-35. body mass male 77 days 10 344.0 g 8.22 26.0 body weighing method 0.0 0 102482 2690
SS/JrIpcv body weight controlled sodium content diet (0.3 %) Hojnż S, et al., Physiol Res. 2005;54(2):201-6. body mass male 0 days 0 271.0 g 10.0 body weighing method 0.0 0 102390 2688
Crlj:WI body weight controlled air oxygen content (5 %) (for 28 days) Chen YC, et al., Am J Physiol Regul Integr Comp Physiol. 2016 Aug 1;311(2):R426-39. doi: 10.1152/ajpregu.00112.2016. Epub 2016 Jun 1. body mass male 16 days 7 300.0 g 5.0 13.23 body weighing method 0.0 0 103000 2784
SD body weight unilateral nephrectomy (between 12 and 14 days) then enalapril (50 mg/l) (between 12 and 14 days) and losartan (180 mg/l) (between 12 and 14 days) Greene EL, et al., J Clin Invest. 1996 Aug 15;98(4):1063-8. body mass male 0 days 5 285.0 g 6.71 15.0 body weighing method 0.0 unx 13 days 101537 2602
SD change in body weight unilateral nephrectomy (for 28 days) Greene EL, et al., J Clin Invest. 1996 Aug 15;98(4):1063-8. body mass male 0 days 8 59.0 g 10.96 31.0 body weighing method 0.0 unx 28 days change from surgery weight 101609 2602
SD change in body weight unilateral nephrectomy (for 28 days) then spironolactone (5.56 mg/kg/d) (for 28 days) Greene EL, et al., J Clin Invest. 1996 Aug 15;98(4):1063-8. body mass male 0 days 8 48.0 g 10.96 31.0 body weighing method 0.0 unx 28 days change from surgery weight 101610 2602
SR/JrHsd body weight controlled sodium content diet (0.1 %) (for 112 days) then bilateral ovariectomy (between 56 and 63 days) and 17 beta-estradiol (5 mg) (between 56 and 63 days) Esqueda ME, et al., Hypertension. 2007 Oct;50(4):768-72. Epub 2007 Aug 13. body mass female 112 days 6 209.5 g 5.3 12.98 body weighing method 0.0 ovx 63 days 102345 2686
SS-Renem1Mcwi+/- body weight controlled sodium content diet (0.4 %) (for 49 days) Moreno C, et al., Hypertension. 2011 Mar;57(3):614-9. doi: 10.1161/HYPERTENSIONAHA.110.163840. Epub 2011 Jan 17. body mass male 70 days 9 321.0 g 11.14 33.42 body weighing method 0.0 0 98291 2038
WKY body weight streptozotocin (60 mg/kg) then gene transfer of the murine angiotensin I converting enzyme 2 gene using an adenovirus vector (40000000000 null) Liu CX, etal., Mol Med. 2011 Jan-Feb;17(1-2):59-69. doi: 10.2119/molmed.2010.00111. Epub 2010 Sep 14. body mass male 156 days 10 295.56 g 21.89 69.22 body weighing method 0.0 0 99110 2219
SD body weight left nephrectomy (for 70 days) then puromycin (100 mg/kg) then anti-Shiga toxin 1 beta monoclonal antibody 13C4 (5 mg/kg) then puromycin (40 mg/kg) Ma LJ, et al., Kidney Int. 2004 Jan;65(1):106-15. body mass male 0 days 7 267.0 g 7.0 18.52 body weighing method 0.0 unx 70 days 98935 2179
SD mean arterial blood pressure left nephrectomy (for 70 days) then puromycin (100 mg/kg) then anti-transforming growth factor beta antibody (5 mg/kg) then puromycin (80 mg/kg) Ma LJ, et al., Kidney Int. 2004 Jan;65(1):106-15. arterial blood pressure trait male 0 days 9 129.0 mmHg 4.0 12.0 body weighing method 0.0 unx 70 days 98948 2179
SR/JrHsd body weight controlled sodium content diet (0.1 %) (for 112 days) then sham surgical control condition (between 56 and 63 days) Esqueda ME, et al., Hypertension. 2007 Oct;50(4):768-72. Epub 2007 Aug 13. body mass female 112 days 6 253.5 g 4.9 12.0 body weighing method 0.0 sham ovx 63 days 102343 2686
GK/Jcl body weight controlled cyclodextrin (CD)-clathrated hesperetin content diet (4.6 %) Akiyama S, et al., Biosci Biotechnol Biochem. 2009 Dec;73(12):2779-82. doi: 10.1271/bbb.90576. Epub 2009 Dec 7. body mass male 24 days 6 166.41 g 2.36 5.78 body weighing method 0.0 0 103911 2884
MW body weight nephrectomy (for 28 days) then reserpine (5 mg/l) (for 21 days) and hydralazine (80 mg/l) (for 21 days) and controlled hydralazine content drinking water (25 mg/l) (for 21 days) Anderson S, et al., J Clin Invest. 1986 Jun;77(6):1993-2000. body mass male 0 days 8 233.0 g 4.0 11.31 body weighing method 0.0 5/6 nephrectomy 28 days 100985 2561
SR/NEisSlc body weight controlled sodium chloride content diet (8 %) (for 7 days) Yoshihara F, et al., Regul Pept. 2005 May 15;128(1):7-13. body mass male 63 days 7 286.0 g 6.05 16.0 body weighing method 0.0 0 102405 2689
SS/NEisSlc body weight controlled sodium chloride content diet (8 %) (for 21 days) Yoshihara F, et al., Regul Pept. 2005 May 15;128(1):7-13. body mass male 77 days 8 342.0 g 4.24 12.0 body weighing method 0.0 0 102410 2689
MWF/ZtmRrrc body weight enalapril (50 mg/l) (for 182 days) Remuzzi A, et al., J Clin Invest. 1990 Feb;85(2):541-9. body mass male 246 days 6 442.0 g 7.35 18.0 body weighing method 0.0 0 100906 2541
WKY body weight 0.9% sodium chloride solution (3 ml) Anderson S, et al., J Clin Invest. 1988 Nov;82(5):1757-68. body mass male 0 days 9 244.0 g 8.0 24.0 body weighing method 0.0 0 100427 2479
SS/JrHsdMcwi body weight control condition McPherson KC, et al., Am J Physiol Renal Physiol. 2016 Oct 1;311(4):F793-F804. doi: 10.1152/ajprenal.00590.2015. Epub 2016 Jul 27. body mass male 42 days 27 176.0 g 6.0 31.18 body weighing method 0.0 0 100067 2418
WKY body weight 0.9% sodium chloride solution (3 ml) Anderson S, et al., J Clin Invest. 1988 Nov;82(5):1757-68. body mass male 0 days 10 241.0 g 5.0 15.81 body weighing method 0.0 0 100391 2479
WF/Mol body weight gain controlled losartan content drinking water (10 mg/kg/d) (for 3 days) then artificial aortocaval fistula (for 2 days) Wahlander H, et al., Acta Physiol Scand. 1999 Feb;165(2):143-54. body mass male 0 days 8 -12.0 g 2.0 5.66 body weighing method 0.0 acf 2 days change from surgery weight 101332 2585
SS.ZUC-Leprfa+/+/Slc body weight bilateral ovariectomy (for 42 days) then vehicle control condition (for 35 days) Murase T, et al., Hypertension. 2012 Mar;59(3):694-704. doi: 10.1161/HYPERTENSIONAHA.111.180976. Epub 2012 Jan 23. body mass female 91 days 9 294.0 g 6.0 18.0 body weighing method 0.0 ovariectomy 42 days 101661 2622
SS.ZUC-Leprfa+/+/Slc body weight bilateral ovariectomy (for 42 days) then 17 beta-estradiol (0.5 mg) (for 35 days) Murase T, et al., Hypertension. 2012 Mar;59(3):694-704. doi: 10.1161/HYPERTENSIONAHA.111.180976. Epub 2012 Jan 23. body mass female 91 days 12 220.0 g 4.0 13.86 body weighing method 0.0 ovariectomy 42 days 101662 2622
SD body weight left anterior descending coronary artery occlusion (for 28 days) Lax CJ, et al., Clin Exp Pharmacol Physiol. 2004 Aug;31(8):512-7. body mass male 77 days 6 403.2 g 7.4 18.13 body weighing method 0.0 lad occlusion 28 days 101075 2564
WF/Mol body weight vehicle control condition then artificial aortocaval fistula (for 7 days) Wahlander H, et al., Acta Physiol Scand. 1999 Feb;165(2):143-54. body mass male 0 days 7 184.0 g 3.0 7.94 body weighing method 0.0 acf 7 days 101306 2585
WF/Mol body weight controlled losartan content drinking water (10 mg/kg/d) (for 3 days) then sham surgical control condition (for 2 days) Wahlander H, et al., Acta Physiol Scand. 1999 Feb;165(2):143-54. body mass male 0 days 6 190.0 g 5.0 12.25 body weighing method 0.0 sham acf 2 days 101311 2585
WF/Mol body weight controlled losartan content drinking water (10 mg/kg/d) (for 5 days) then sham surgical control condition (for 4 days) Wahlander H, et al., Acta Physiol Scand. 1999 Feb;165(2):143-54. body mass male 0 days 6 184.0 g 2.0 4.9 body weighing method 0.0 sham acf 4 days 101315 2585
WF/Mol body weight controlled losartan content drinking water (10 mg/kg/d) (for 8 days) then artificial aortocaval fistula (for 7 days) Wahlander H, et al., Acta Physiol Scand. 1999 Feb;165(2):143-54. body mass male 0 days 7 203.0 g 3.0 7.94 body weighing method 0.0 acf 7 days 101318 2585
WF/Mol body weight gain controlled ramipril content drinking water (3 mg/kg/d) (for 8 days) then sham surgical control condition (for 7 days) Wahlander H, et al., Acta Physiol Scand. 1999 Feb;165(2):143-54. body mass male 0 days 5 30.0 g 2.0 4.47 body weighing method 0.0 sham acf 7 days change from surgery weight 101327 2585
WF/Mol body weight gain vehicle control condition then artificial aortocaval fistula (for 7 days) Wahlander H, et al., Acta Physiol Scand. 1999 Feb;165(2):143-54. body mass male 0 days 5 12.0 g 3.0 6.71 body weighing method 0.0 acf 7 days change from surgery weight 101328 2585
BN-Chr 13SS/Mcwi body weight control condition Stodola TJ, et al., Physiol Genomics. 2011 Jul 14;43(13):808-17. doi: 10.1152/physiolgenomics.00171.2010. Epub 2011 Apr 26. body mass male 49 days-63 days 12 215.3 g 6.9 23.9 body weighing method 0.0 0 99007 2198
F344-Hsd11b2em1Jmul-/- body weight standard rat chow Mullins LJ, et al., Hypertension. 2015 Sep;66(3):667-73. doi: 10.1161/HYPERTENSIONAHA.115.05262. Epub 2015 Jun 15. body mass male 98 days 7 276.7 g 4.1 10.85 body weighing method 0.0 0 104989 3008
Crl:WI(WU) body weight abdominal aortic constriction then quinapril (2 mg/kg/d) (for 14 days) Goetz RM and Holtz J, Clin Sci (Lond). 1999 Aug;97(2):165-74. body mass male 91 days 11 284.0 g 7.0 23.22 body weighing method 0.0 aorta coarctation 35 days 100008 2398
SD body weight sham surgical control condition (for 6 hours) Seqqat R, et al., J Mol Cell Cardiol. 2012 Aug;53(2):240-9. doi: 10.1016/j.yjmcc.2012.05.004. Epub 2012 May 15. body mass male 0 days 6 291.0 g 10.0 24.49 body weighing method 1.0 sham ACF 360 min 98756 2160
SS.ZUC-Leprfa-/-/Slc body weight control condition Hattori T, et al., Nutr Diabetes. 2011 Jan 31;1:e1. doi: 10.1038/nutd.2010.1. body mass male 126 days 7 536.92 g 6.98 18.47 body weighing method 0.0 0 101886 2642
SD-Nfe2l2em1Mcwi+/+ body weight controlled sodium content diet (0.4 %) (between 70 and 84 days) Priestley JR, et al., Am J Physiol Heart Circ Physiol. 2016 Feb 15;310(4):H478-87. doi: 10.1152/ajpheart.00586.2015. Epub 2015 Dec 4. body mass male 10 days-12 days 4 290.0 g 11.1 22.2 body weighing method 0.0 0 100731 2520
SD-Nfe2l2em1Mcwi-/- body weight controlled sodium content diet (0.4 %) (between 70 and 84 days) Priestley JR, et al., Am J Physiol Heart Circ Physiol. 2016 Feb 15;310(4):H478-87. doi: 10.1152/ajpheart.00586.2015. Epub 2015 Dec 4. body mass male 10 days-12 days 4 287.0 g 26.7 53.4 body weighing method 0.0 0 100732 2520
SD-Nfe2l2em1Mcwi+/+ body weight controlled sodium content diet (0.4 %) (between 70 and 84 days) then controlled sodium content diet (4 %) (for 6 days) then vehicle control condition (for 3 days) Priestley JR, et al., Am J Physiol Heart Circ Physiol. 2016 Feb 15;310(4):H478-87. doi: 10.1152/ajpheart.00586.2015. Epub 2015 Dec 4. body mass male 9 days-11 days 8 281.0 g 17.7 50.06 body weighing method 0.0 0 100733 2520
SD-Nfe2l2em1Mcwi-/- body weight controlled sodium content diet (0.4 %) (between 70 and 84 days) then controlled sodium content diet (4 %) (for 6 days) then vehicle control condition (for 3 days) Priestley JR, et al., Am J Physiol Heart Circ Physiol. 2016 Feb 15;310(4):H478-87. doi: 10.1152/ajpheart.00586.2015. Epub 2015 Dec 4. body mass male 9 days-11 days 4 299.0 g 22.2 44.4 body weighing method 0.0 0 100734 2520
SD-Nfe2l2em1Mcwi+/+ body weight controlled sodium content diet (0.4 %) (between 70 and 84 days) then controlled sodium content diet (4 %) (for 6 days) then angiotensin II (100 ng/kg/min) (for 3 days) Priestley JR, et al., Am J Physiol Heart Circ Physiol. 2016 Feb 15;310(4):H478-87. doi: 10.1152/ajpheart.00586.2015. Epub 2015 Dec 4. body mass male 9 days-11 days 6 291.0 g 11.6 28.41 body weighing method 0.0 0 100735 2520
MW body weight right nephrectomy (for 84 days) then enalapril (20 mg/kg/d) (for 28 days) Kakinuma Y, et al., Kidney Int. 1992 Jul;42(1):46-55. body mass male 0 days 9 299.6 g 11.7 35.1 body weighing method 0.0 ~5/6 to 7/8 nephrectomy 84 days 100823 2523
MW body weight right nephrectomy (for 112 days) Kakinuma Y, et al., Kidney Int. 1992 Jul;42(1):46-55. body mass male 0 days 6 283.2 g 19.9 48.74 body weighing method 0.0 ~5/6 to 7/8 nephrectomy 112 days 100827 2523
MW body weight right nephrectomy (for 112 days) then captopril (30 mg/kg/d) (for 56 days) Kakinuma Y, et al., Kidney Int. 1992 Jul;42(1):46-55. body mass male 0 days 10 320.6 g 15.0 47.43 body weighing method 0.0 ~5/6 to 7/8 nephrectomy 112 days 100829 2523
WI body weight swimming with water weights (for 1 hours) Ma Z, et al., Eur J Appl Physiol. 2013 Oct;113(10):2473-86. doi: 10.1007/s00421-013-2685-9. Epub 2013 Jun 28. body mass female 0 days 16 267.2 g 3.35 13.4 body weighing method 1.0 swim 1 days following 8 wk protocol 98747 2159
SS.BN-(D13Hmgc64-D13Hmgc23)/Mcwi body weight control condition Stodola TJ, et al., Physiol Genomics. 2011 Jul 14;43(13):808-17. doi: 10.1152/physiolgenomics.00171.2010. Epub 2011 Apr 26. body mass male 49 days-63 days 12 268.3 g 7.5 25.98 body weighing method 0.0 0 98999 2198
MNS body weight streptozotocin (55 mg/kg) then insulin (4 IU/kg) (for 84 days) Pugliese G, et al., Kidney Int. 2005 Apr;67(4):1440-52. doi: 10.1111/j.1523-1755.2005.00221.x. body mass male 168 days 8 370.0 g 13.79 39.0 body weighing method 0.0 0 104065 2907
BDIX/Orl body weight Azoxymethane (15 mg/kg) Kobaek-Larsen M, etal., Comp Med. 2002 Feb;52(1):50-7. body mass female 119 days-0 days 8 232.0 g 3.15 8.9 body weighing method 0.0 0 body weight 107002 3074
MWF/FubRkb fetal body weight control condition Schulte L, etal., J Hypertens. 2012 Oct;30(10):2031-8. doi: 10.1097/HJH.0b013e328356a60a. body mass not specified -6 days 11 0.26 g 0.01 0.03 body weighing method 0.0 0 109501 3145
MWF-Chr 6SHR/Rkb fetal body weight control condition Schulte L, etal., J Hypertens. 2012 Oct;30(10):2031-8. doi: 10.1097/HJH.0b013e328356a60a. body mass not specified -6 days 12 0.27 g 0.01 0.02 body weighing method 0.0 0 109505 3145
SHR/FubRkb fetal body weight control condition Schulte L, etal., J Hypertens. 2012 Oct;30(10):2031-8. doi: 10.1097/HJH.0b013e328356a60a. body mass not specified -5 days 10 0.24 g 0.01 0.02 body weighing method 0.0 0 109507 3145
MWF/FubRkb fetal body weight control condition Schulte L, etal., J Hypertens. 2012 Oct;30(10):2031-8. doi: 10.1097/HJH.0b013e328356a60a. body mass not specified -6 days 11 0.26 g 0.01 0.03 body weighing method 0.0 0 109508 3145
LOU/MWsl change in body weight to initial body weight ratio rat IgM immunocytoma cells (1 x 10E4 cells) then doxorubicin (1 mg/kg) (for 10 days) van Hoesel QG, etal., Cancer Res. 1984 Sep;44(9):3698-705. body mass male 105 days-115 days 6 -8.1 % body weighing method 0.0 0 109575 3150
LOU/MWsl change in body weight to initial body weight ratio rat IgM immunocytoma cells (1 x 10E4 cells) then positively charged liposome-entrapped doxorubicin (1 mg/kg) (for 10 days) van Hoesel QG, etal., Cancer Res. 1984 Sep;44(9):3698-705. body mass male 105 days-115 days 6 -3.2 % body weighing method 0.0 0 109577 3150
SBH/Ygl body weight controlled sodium chloride content diet (0.65 %) (for 98 days) Landau D, et al., J Endocrinol. 2008 Apr;197(1):75-83. doi: 10.1677/JOE-08-0040. body mass male 98 days 7 295.0 g 10.0 26.46 body weighing method 0.0 0 106700 3038